Expanded Access Program to Provide Bamlanivimab (LY3819253) for the Treatment of COVID-19

NCT04603651 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Bamlanivimab

Sponsor

Eli Lilly and Company

Collaborators

[object Object]